Primary Myelofibrosis (PMF)

Videos

Overview

Understanding Myelofibrosis

Myelofibrosis - causes, symptoms, diagnosis, treatment, pathology

Myelofibrosis Prognostic Scoring Systems: IPSS, DIPSS, DIPSS-Plus, MISPS, and GIPSS

Primary Myelofibrosis (PMF) | Myeloproliferative Neoplasm| Bone Marrow Fibrosis

Reiki for Bone Marrow Disorder Myelofibrosis/Energy Healing

Primary myelofibrosis (PMF) is a rare bone marrow blood cancer. It is classified by the World Health Organization (WHO) as a type of myeloproliferative neoplasm, a group of cancers in which there is growth of abnormal cells in the bone marrow. This is most often associated with a somatic mutation in the JAK2, CALR, or MPL gene markers. In PMF, the healthy marrow is replaced by scar tissue (fibrosis), resulting in a lack of production of normal blood cells. Symptoms include anemia, increased infection and an enlarged spleen (Spleen Enlargement (Splenomegaly)).

In 2016, prefibrotic primary myelofibrosis was formally classified as a distinct condition that progresses to overt PMF in many patients, the primary diagnostic difference being the grade of fibrosis

Anemia associated with myelofibrosis may respond positively pyridoxine hydrochloride.

Myelofibrosis and Combined, L-Carnitine (LC), Curcumin, Lactoferrin and Human EPO Therapy

**PRM-151 therapy well tolerated in patients with advanced myelofibrosis**